Beigene

BGNE

BGNE Beigene NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    BGNE Chart
    See on advanced chart >

    About

    Beigene, Ltd. established on October 28, 2010,is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the...
    • Highlight
      A Chinese developer of innovative, molecularly targeted and immuno-oncology drugs to treat cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/03/2016
    • Established Date
      10/28/2010
    • Full-time Employees
      10,600
    • Address
      No. 30 Science Park Road Zhong-Guan-Cun Life Science Park Changping District Beijing PRC
    • Tel
      86-10-58958058
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)